Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

FDA’s Strategic Plan Emphasizes Science

by David J. Hanson
April 25, 2011 | A version of this story appeared in Volume 89, Issue 17

In the wake of getting new responsibilities for food and drug safety, FDA has issued a “strategic priorities document” to guide the agency’s actions through 2015. “It is clear that FDA’s job is … far more complex than it was even a few years ago,” said FDA Commissioner Margaret A. Hamburg in a statement. “Science underlies everything we do. … We must have the capacity to effectively oversee the translation of breakthrough discoveries in science into innovative, safe, and effective products.” FDA lists five priorities in its plan: advance regulatory science and innovation, strengthen the safety and integrity of the global supply chain, strengthen compliance and enforcement activities to support public health, address unmet public health needs of special populations, and advance medical countermeasures and emergency preparedness.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.